Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vertex Pharmaceuticals (NQ: VRTX ) 455.31 +1.76 (+0.39%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Vertex Pharmaceuticals < Previous 1 2 3 4 5 6 7 8 9 ... 52 53 Next > Here's How Much $100 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth Today July 23, 2024 Via Benzinga 3 Gene Editing Stocks Shaping the Future of Medicine July 22, 2024 Gene editing stocks offer a bold venture into biopharma's future, leveraging CRISPR technology for transformative healthcare solutions Via InvestorPlace 2 Historically Flawless Metrics Suggest the Stock Market Can Plunge: Here Are 3 Stocks I've Sold Ahead of What May Be a Big Move for Wall Street July 21, 2024 Neither of these predictive indicators has ever been wrong when back-tested for more than 150 years! Via The Motley Fool 3 Monster Stocks in the Making to Buy Right Now July 20, 2024 They're small now, but these stocks could grow much larger. Via The Motley Fool The 3 Best Neuroscience Biotech Stocks to Buy Now July 19, 2024 Given the high bar to developing good neuroscience drugs, firms that do so will likely succeed. Here are three top biotech stocks to buy now. Via InvestorPlace Forecasting The Future: 13 Analyst Projections For Vertex Pharmaceuticals July 11, 2024 Via Benzinga Check Out What Whales Are Doing With VRTX July 10, 2024 Via Benzinga Why the quality investor may take a look at NASDAQ:VRTX. July 03, 2024 Examining the Quality Attributes of NASDAQ:VRTX. Via Chartmill Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings July 29, 2024 The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say following its July meeting. Via Benzinga Topics Economy Exposures Interest Rates 2 No-Brainer Growth Stocks to Buy With $1,000 Right Now July 28, 2024 These companies are paving the way to future growth and market share in their respective industries. Via The Motley Fool Is Vertex Pharmaceuticals' Monopoly in Danger? July 25, 2024 As a shareholder, I am nowhere close to panic mode. Via The Motley Fool Why VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) qualifies as a quality stock. July 25, 2024 Is VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) suited for quality investing? Via Chartmill 3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow July 25, 2024 Vertex shares have soared by triple-digit percentages over the past three years. Via The Motley Fool 7 Biotech Stocks to Keep on Your Clinical Radar July 23, 2024 Biotech stocks have always been relevant. However, with the latest shift in the political race, this sector is bound to grab more eyeballs. Via InvestorPlace Looking for growth without the hefty price tag? Consider NASDAQ:VRTX. July 19, 2024 VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) is not too expensive for the growth it is showing. Via Chartmill 3 Gene Editing Stocks That Could Grow Your Wealth July 17, 2024 Investors looking for gene editing stocks of cutting edge technology firms should consider these biotech stocks. Via InvestorPlace Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals? July 16, 2024 CRISPR Therapeutics could start reporting product revenue soon. Via The Motley Fool Bull Market and Beyond: 2 Stocks Just Waiting to Soar July 15, 2024 These innovative drugmakers are hard to ignore. Via The Motley Fool Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split July 15, 2024 Revenue is climbing at these two drug companies -- and the trend should continue. Via The Motley Fool Got $1,000? 2 Incredible Growth Stocks to Buy and Hold Forever July 14, 2024 These companies have what it takes to stand the test of time in a portfolio. Via The Motley Fool The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024 July 09, 2024 Finding undervalued gene editing stocks is easy, but having the patience to stick with them is the challenge. Via InvestorPlace Healthcare Stocks Continue To Lag The Market-Can Anything Help ? July 08, 2024 Healthcare stocks continue to lag the market up about 6% YTD, helped by Large Cap Biopharma but hurt by United Health. Via Talk Markets 3 No-Brainer Stocks to Buy in July July 08, 2024 Investors shouldn't have to think too hard about these great stocks. Via The Motley Fool 3 Pharma Stocks Already Ushering in the Next Biotech Boom July 08, 2024 So long as diseases afflict the human condition, there will likely always be a need for pharma stocks. Here are three to consider. Via InvestorPlace Prediction: This Will Be Vertex Pharmaceuticals' New Billion-Dollar Growth Driver (and It's Coming Soon). July 06, 2024 Vertex shares have advanced by triple digits over the past few years. Via The Motley Fool The 3 Best Biotech Stocks to Buy in July 2024 July 05, 2024 For investors looking for promising biotech investments should explore the best biotech stocks to watch in July 2024. Via InvestorPlace 1 Stock That Increased 10,000% in 33 Years to Buy and Hold Forever July 05, 2024 It's not too late to get in on the act. Via The Motley Fool Did Vertex Pharmaceuticals Just Invent the Next Ozempic? July 05, 2024 Vertex Pharmaceuticals likely has a breakthrough medicine on its hands. Via The Motley Fool Forget Eli Lilly: 3 Biotech Stocks to Buy Instead July 04, 2024 Eli Lilly is a good stock to buy, but these should be even better. Via The Motley Fool 3 Top-Rated Gene Editing Stocks Actually Making Money July 03, 2024 Profitable gene editing stocks make increasingly compelling investments as therapies commercialize this year and beyond. Via InvestorPlace < Previous 1 2 3 4 5 6 7 8 9 ... 52 53 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.